Retrospective observational study in patients with renal cell carcinoma treated by everolimus, mTOR inhibitor

Retrospective observational study in patients with renal cell carcinoma treated by everolimus, mTOR inhibitor - Retrospective observational study in patients with renal cell carcinoma treated by everolimus, mTOR inhibitor

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000004730

Enrollment

300

Registered

2010-12-15

Start date

2010-12-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Advanced renal cell carcinoma

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Unresectable or metastatic patients with renal cell carcinoma treated by everolimus 2) Patients who did not refuse against the provision of treatment data

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

Measure	Time frame
Safety	—

Secondary

Measure	Time frame
1) ORR 2) PFS	—

Countries

Japan

Contacts

Public ContactKazuhiro Yoshimura

Kinki University School of Medicine Department of Urology

072-366-0221

Outcome results